Is Ritodrine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Ritodrine.

Is Ritodrine approved by the US FDA?

Drugs@FDA lists 9 application product lines for Ritodrine, including YUTOPAR (Discontinued); RITODRINE HYDROCHLORIDE (Discontinued); RITODRINE HYDROCHLORIDE (Discontinued); RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER (Discontinued); RITODRINE HYDROCHLORIDE (Discontinued).

Active substance

Ritodrine

SFDA 2
US FDA 9

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
YUTOPAR 10MG TABLET	10 mg	Tablet · Oral use	20 Blister	SAR 37.25	NCE · Prescription	SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO	Withdrawn by regulatory authority · Not Marketed
YUTOPAR 50MG-5ML I.V. AMPOULE	10 mg/ml	Injection · Intravenous use	2 Ampoule	SAR 33.40	NCE · Prescription	SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO	Withdrawn by regulatory authority · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
YUTOPAR	10MG	tablet · oral	ASTRAZENECA	Discontinued	12 Dec 1980
RITODRINE HYDROCHLORIDE	10MG/ML	injectable · injection	ABRAXIS PHARM	Discontinued	23 Jul 1987
RITODRINE HYDROCHLORIDE	15MG/ML	injectable · injection	ABRAXIS PHARM	Discontinued	23 Jul 1987
RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	30MG/100ML	injectable · injection	HOSPIRA	Discontinued	22 Jan 1991
RITODRINE HYDROCHLORIDE	10MG/ML	injectable · injection	HOSPIRA	Discontinued	28 Feb 1991
RITODRINE HYDROCHLORIDE	15MG/ML	injectable · injection	HOSPIRA	Discontinued	28 Feb 1991
RITODRINE HCL	10MG/ML	injectable · injection	QUAD PHARMS	Discontinued
RITODRINE HCL	15MG/ML	injectable · injection	QUAD PHARMS	Discontinued
YUTOPAR	10MG/ML; 15MG/ML	injectable · injection	ASTRAZENECA	Discontinued

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.